Corporate News Update – Citrotech Inc.
Market Performance (24‑hour period ending 06:43 PM CET, Friday 23 Oct 2026)
- Closing price: USD 2.58
- Day‑to‑day change: +1.54 %
- 24‑hour volume: USD 511.1 k
- Shares outstanding: 22.6 million
- Market capitalization: USD 59.5 million
- 52‑week high: USD 10.37 (20 Mar 2026)
- 52‑week low: USD 2.20 (21 Oct 2026)
- 200‑day simple moving average: USD 6.42
- Month‑end change: –42.61 %
Recent Filing – 8‑K (21 Oct 2026) Citrotech Inc. reported a firm‑commitment public offering of 2.24 million shares at USD 2.50 per share. The offering was priced on 20 Oct 2026, executed through Univest Securities, LLC. The underwriters have a 45‑day option to purchase an additional 336,000 shares. The registration statement and prospectus were declared effective on 20 Oct, and the offering closed on 22 Oct. Net proceeds will be used for working capital and general corporate purposes. Shares will trade on NYSE American under the ticker CITR. The company remains a smaller reporting company and continues to emphasize environmentally friendly fire‑inhibitor products, including a joint venture for commercialization in lumber and wood products.
Peer Activity (last 24 hours)
| Symbol | Current Price | % Change | Market Cap (USD mn) | Notes |
|---|---|---|---|---|
| LNSR (Lensar) | 5.93 | –2.07 % | 69.9 | PE ratio: 6.34 |
| CGTX (Cognition Therapeutics) | 0.72 | +1.77 % | 71.0 | FDA Phase 3 confirmation for CT1812 in dementia with Lewy bodies |
| MAIA (Maia Biotechnology) | 1.15 | +1.79 % | 70.4 | – |
| MNOV (Medicino) | 1.41 | 0 % | 69.7 | – |
| BYFC (Broadway /De) | 11.26 | 0 % | 69.9 | – |
Company Profile Citrotech Inc. is an American company listed on the OTC Bulletin Board. The entity operates under the parent company General Enterprise Ventures Inc. The company focuses on the development and commercialization of fire‑inhibitor products and related services with a commitment to environmental sustainability.
